Strategic partnerships Koios Medical has active and expanding partnerships with major imaging and analytics players including Philips, SimonMed, RamSoft, iCAD, and involvement in multi-modality integration efforts. This presents recurring collaboration and channel opportunities for co-marketed solutions and expanded hospital footprints.

FDA clearance leverage The AI-powered Koios DS is FDA cleared for use in the USA, a strong differentiator for sales conversations with radiology departments seeking compliant, enterprise-ready decision support that can reduce diagnostic uncertainty and speed up workflows.

Clinical integration Koios integrates with existing radiology workflows and systems (RIS/PACS, multi-modality partners) via distributors and integration partners, signaling readiness for enterprise deployments and upsell opportunities to radiology IT teams seeking seamless AI augmentation.

Healthcare demand signals Recent partnerships with Philips, RamSoft, iCAD and participation in ECR 2025 indicate growing market demand for AI-assisted breast and thyroid cancer detection, suggesting a receptive environment for expansion into new hospital networks and regional accounts.

Financial foothold With mid-market revenue range and a $13M funding base, Koios has financial momentum to pursue enterprise pilots and gradually scale. This supports structured outreach to mid-to-large health systems and regional networks seeking proven ROI from AI clinical decision support.